Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 506 entries
View as:

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00003883 Org: User:
Start: 10/31/98 End: 07/31/02 Due: 07/31/03

MMF for HIV Reservoir Reduction

Phase: N/A Priority: Normal
NCT ID: NCT03262441 Org: User:
Start: 02/12/18 End: 08/31/19 Due: 08/31/20

Comparing Different Methods for Collection of Comorbidity Data Per the HCT-CI

Phase: N/A Priority: Normal
NCT ID: NCT03434561 Org: User:
Start: 03/22/13 End: 06/30/16 Due: 06/30/17

The Vaginal Health Trial

Phase: N/A Priority: Normal
NCT ID: NCT02516202 Org: User:
Start: 04/30/16 End: 07/31/17 Due: 07/31/18

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Phase: N/A Priority: Normal
NCT ID: NCT00036738 Org: User:
Start: 07/13/01 End: 05/31/18 Due: 05/31/19

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00621452 Org: User:
Start: 08/31/07 End: - Due: -

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01894477 Org: User:
Start: 11/30/13 End: 06/30/22 Due: 06/30/23

Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01005537 Org: User:
Start: 06/30/09 End: - Due: -

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT03670069 Org: User:
Start: 09/30/19 End: 05/06/24 Due: 05/06/25

Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT01831232 Org: User:
Start: 05/31/13 End: 01/31/16 Due: 01/31/17

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04466475 Org: User:
Start: 01/27/24 End: 09/30/27 Due: 09/30/28

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00003954 Org: User:
Start: 03/31/99 End: - Due: -

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04496219 Org: User:
Start: 01/22/21 End: 08/23/22 Due: 08/23/23

Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00217568 Org: User:
Start: 05/31/05 End: - Due: -

Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)

Phase: N/A Priority: Normal
NCT ID: NCT03585231 Org: User:
Start: 09/17/18 End: 12/02/20 Due: 12/02/21

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00555048 Org: User:
Start: 09/30/07 End: - Due: -

Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit)

Phase: N/A Priority: Normal
NCT ID: NCT01812070 Org: User:
Start: 03/31/13 End: 08/31/13 Due: 08/31/14

Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02750904 Org: User:
Start: 04/03/17 End: 05/14/19 Due: 05/14/20

Diet and Metabolic Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT02539355 Org: User:
Start: 08/31/15 End: 09/30/16 Due: 09/30/17

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01957709 Org: User:
Start: 09/25/13 End: 06/01/18 Due: 06/01/19

Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00317759 Org: User:
Start: 05/31/03 End: 10/31/08 Due: 10/31/09

MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation

Phase: N/A Priority: Normal
NCT ID: NCT01178892 Org: User:
Start: 11/30/10 End: 05/31/12 Due: 05/31/13

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00110058 Org: User:
Start: 02/28/05 End: 07/31/06 Due: 07/31/07

Effects of Garlic Supplements on Drug Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00122889 Org: User:
Start: 07/31/05 End: 03/31/09 Due: 03/31/10

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00093366 Org: User:
Start: 06/30/04 End: 07/31/06 Due: 07/31/07